Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

MELOXICAM TABLETS

Awarded
SPE2DP22F5070Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded contract SPE2DP22F5070 to DMS Pharmaceutical Group Inc for the procurement of Meloxicam Tablets under the broader delivery order SPE2DX15D9383. While the overarching commercial items contract dated April 30, 2015, carried a total award value of 4,999,999.00 dollars and included specific FAR clauses and DPAS rating requirements, this particular award notice was posted on August 25, 2026. Subsequent to the award, Modification P00001 was issued by DLA Troop Support to effectuate a total cancellation of CLIN 0001 for the Meloxicam Tablets. This action was taken because the delivery orders were aged and unperformed, and the associated ships were being decommissioned. This modification decreased the contract amount by 6.02 dollars, resulting in a final total contract value of 0.00 dollars.

General Info

DLA cancelled Meloxicam Tablets contract with DMS Pharmaceutical Group, reducing total value to zero.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Documents

2
PDF, High priority: read this firstmodification
High
PDF, High priority: read this firstaward
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP22F5070 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: See Award Doc Award Date: 08-25-2026 Delivery order under: SPE2DX15D9383 Line items: - MELOXICAM TABLETS (NSN/Part 6505015413243)

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENT
Solicitation # SPE2DP-27-T-0233
Solicitation SPE2DP-27-T-0233, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotations for the procurement of Dibucaine Ointment, USP. The required product is a rectal ointment containing 1 percent dibucaine as the active ingredient, supplied in a collapsible tube with a rectal applicator. Each unit of issue consists of one package containing one ounce or 28 grams. The product must be stored between 15 and 30 degrees Celsius and is intended for external, rectal administration. The procurement specifies a quantity of one package with a required delivery date of November 5, 2026, and a delivery lead time of 20 days after order. The contract mandates strict adherence to quality and packaging standards, including USP standards, MIL-STD-129 for marking, and Medical Marking Standard No. 1. Packaging must comply with DLA Packaging Requirements for Procurement (RP001) and ASTM D3951 for non-hazardous materials, while hazardous materials must follow TQ requirement IP025 and FED-STD-313. Delivery is FOB Destination, with inspection and acceptance also occurring at the destination. Payment and receiving reports must be processed electronically through the Wide Area WorkFlow (WAWF) system. Key regulatory and legal requirements include compliance with the Buy American Act, the Berry Amendment, and DFARS regulations regarding the safeguarding of covered defense information and the prohibition of certain telecommunications equipment. Offerors must be registered in the System for Award Management (SAM) and provide necessary representations and certifications regarding their business size and socioeconomic status. Quotations are to be submitted via the DIBBS portal by November 9, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS